Abstract: DmmA is a haloalkane dehalogenase (HLD) identified and characterized from the metagenomic DNA of a marine microbial consortium. Dehalogenase activity was detected with 1,3-dibromopropane as substrate, with steady-state kinetic parameters typical of HLDs (K m 5 0.24 6 0.05 mM, k cat 5 2.4 6 0.1 s
Introduction
Haloalkane dehalogenases (HLDs) remove halogens from alkanes by hydrolysis, producing an alcohol, a halide ion, and a proton. These dehalogenating enzymes are of long-standing interest for industrial applications such as degradation of environmental pollutants 1,2 and biocatalysis. 3 Newer applications include remediation of chemical weapons, 4 biosensing, 5, 6 and cellular imaging. 7 The applications for
HLDs are growing with knowledge of their functional and structural properties. Each HLD has a unique substrate selectivity, which can include chlorinated, brominated, and iodinated alkanes of varying length. Some HLDs also act on ring-containing substrates, or those with alcohol, ether, nitrile, or alkene functional groups. 8 Substrate selectivity is not easily predicted by sequence analysis. For HLDs of known structure, the size and shape of the active-site cavity are better predictors of substrate preference than is phylogenetic analysis. 8 The natural substrates are, in general, unknown.
HLDs are members of the a/b hydrolase superfamily, with the active site located between a conserved core subdomain and a more variable lid structure. The HLD active site departs from the typical a/b hydrolase catalytic triad by the replacement of the common Ser nucleophile with an Asp and the addition of two halide-stabilizing residues (Trp and Trp/Asn) to form a ''catalytic pentad.'' 9 The side chains of the catalytic pentad are identically positioned in the active site cleft of all HLDs of known structure, although some pentad residues vary in their locations in the primary sequence. This sequence-location difference of the catalytic pentad residues defines three evolutionary subfamilies of HLDs. 10 Two structures are known from evolutionary subfamily I (DhlA [11] [12] [13] and DppA 14 ) , and four from subfamily II (DhaA, 15, 16 LinB, [17] [18] [19] [20] DbjA, 21 and Rv2578 22 ). Several structures include bound substrates, products, or covalent intermediates, which together with many kinetic studies, led to a detailed reaction mechanism for this enzyme class. 9 DmmA is a putative HLD of subfamily II. 10 This protein was originally annotated as CurN, and presumed to be the final gene product of the curacin A biosynthetic gene cluster 23 from the marine cyanobacterium Lyngbya majuscula (now designated Moorea producta 24 ). However, resequencing revealed the authentic 3 0 end of the gene cluster, which lacks curN, 25 suggesting that dmmA was cloned as part of a chimeric cosmid from the original metagenomic DNA library. 23 Herein, we present the crystal structure and HLD activity of DmmA.
Results

Biological source of DmmA (formerly CurN)
In the original curacin pathway sequencing, 23 DNA encoding 64 amino acids at the CurN N-terminus overlapped with DNA encoding the CurM C-terminus in a different reading frame. This unusually long overlap and peculiarities of the CurM protein sequence led us to isolate a new cosmid, and to resequence the curM-curN region of the gene cluster, resulting in a corrected 3 0 terminus that lacked curN. 25 In addition, no CurN coding sequence was identified by amplification from M. producta (formerly L. majuscula) genomic DNA, nor was CurN located in the recently sequenced M. producta 3L genome. 26 Furthermore, the G þ C content of curN (61%) contrasts with the rest of the curacin biosynthetic gene cluster (45.5%). The scaffolds used to assemble the M. producta genome ranged from 37 to 66% G þ C content, with the great majority falling between 40 and 45%. 26 In addition, CurN (now referred to as DmmA (dehalogenase A from a marine microbe) in accord with other dehalogenases of unknown biological function 8 ) has high similarity ($50%) to HLDs from other marine bacteria, although none are from the cyanobacterial phyla. From these data, we conclude that curN (dmmA) is most likely a product of one of the organisms that grew in close association with the M. producta field isolate whose metagenomic DNA cosmid library was used to sequence the cur gene cluster. It is evident that the 3 0 end of the curacin gene cluster concatenated with curN (dmmA) genetic material from one of the heterotroph bacteria that was growing on the M. producta filament at the time of cosmid preparation. Because the biological source and the natural termini of DmmA are uncertain, we turned to sequence analysis to design dmmA constructs for protein expression. HLD homologs have C-termini of very similar length and sequence to the DmmA Cterminus, but the N-termini are poorly conserved and of variable length. 10 In addition, Fig. 1 ). In addition, several other annotated HLDs have N-termini of similar length to DmmA. 10 Thus, we conclude that the natural protein likely includes all the residues encoded in the curN (dmmA) open reading frame. Two dmmA constructs were made, one encoding the full-length protein (DmmA long , residues 1-341) and one with a 43-residue N-terminal truncation (DmmA short , residues 44-341) to produce a potentially more structured N-terminus (Supporting Information Fig. 2 ). Both DmmA short and DmmA long were produced in high yield, as stable and soluble proteins in an E. coli expression system.
HLD activity
As for many other HLDs, the natural substrate for DmmA is unknown. Small di-halogenated alkanes are typical substrates to assess the activity of HLDs. We chose 1,3-dibromopropane, a standard substrate, for DmmA assays. HLD activity was tested in a colorimetric assay to detect the production of protons. 27, 28 Both DmmA short and DmmA long were active in this assay, however DmmA short exhibited tenfold higher activity than the longer form of the protein ( Table I ), suggesting that the N-terminus may interfere with catalysis. Steady-state kinetic constants were determined for DmmA short (Table II) , which revealed that these parameters are comparable to other HLDs. 15, 27, 29 DhlA has threefold greater catalytic efficiency than DmmA for 1,3-dibromopropane (fourfold lower k cat , 12-fold lower K m ), 27 whereas
DhaA has a nearly equal k cat and a 50-fold lower K m for 1,3-dibromopropane resulting in a 50-fold greater catalytic efficiency. 29 
Structure of DmmA
We solved crystal structures for both DmmA short and DmmA long (Table III) . The first structure was determined from selenomethionyl DmmA short (2.2 Å ). DmmA long (2.9 Å ) was solved from the DmmA short structure. The short and long variants crystallized under different conditions in different crystal forms, each with two polypeptides per asymmetric unit. The two structures thus provide four independent views of the DmmA dehalogenase. Due to the higher-resolution of DmmA short , our efforts focused on analysis of that form of the protein.
DmmA adopts the a/b hydrolase fold as expected [ Fig. 1(A) ], consisting of core and lid sub-domains with the active site at the top of the core, which is covered by the lid [ Fig. 1(A,B) ]. DmmA short and DmmA long are identical within experimental error (root-mean-square deviation (RMSD) ¼ 0.32 Å for 298 Ca atoms). The DmmA short structure is complete with no disordered residues. In DmmA long , six additional N-terminal residues are visible compared with DmmA short , but 37 residues at the N-terminus are disordered [ Fig. 1(C) ].
DmmA oligomeric state
A common protein-protein contact exists in the unrelated crystal forms of DmmA long and DmmA short . The contact has twofold (non-crystallographic) symmetry, Fig. 1(D) ]. The small size of the interface led us to question whether it exists in solution. Other HLDs have been characterized as monomers, dimers, or dimers only under low-salt conditions. Among HLDs of known structure, only DbjA is dimeric in solution. 36 The helix a10 is central to the subunit contacts in both DmmA and DbjA, but the interfaces otherwise differ (Supporting Information  Fig. 3 ). The quaternary structure in solution was probed by analytical gel filtration chromatography. Both DmmA short and DmmA long eluted with apparent Information Fig. 4) . This result implies a dynamic equilibrium between monomeric and dimeric forms, however the retention volume did not change over a 20-fold concentration range of either DmmA short or DmmA long . In addition, the larger buried surface in the putative DmmA long dimer compared to DmmAshort does not result in a more dimeric retention volume. Thus, we conclude that the interface observed in the crystal structures does not represent an interface in solution and that DmmA is monomeric. The The catalytic pentad is shown in sticks and bound halide ion as a sphere for DmmA (green C), LinB 1IZ8 19 (orange C), Rv2578 2O2I 22 (yellow C), DbjA 3A2M 21 (purple C), and DhaA 1CQW 15 (mauve C). Bound malonate is shown for DmmA and bound product, 1,3-propandiol, for Rv2578 (yellow C) and LinB (orange C).
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aberrant elution volumes may result from the dynamic behavior of a monomeric DmmA.
DmmA active site
The active site has an intact and well ordered catalytic pentad, consisting of the nucleophile (Asp144), base (His315), acid (Glu168), and two halide-stabilizing residues (Trp145 and Asn78) [ Fig. 2(A,B) ]. The nucleophile (Asp144), base (His315), and Trp145 are conserved in all HLDs. Asn78 is conserved in subfamilies II and III, and Glu168 is present only in subfamily II. The catalytic pentad resides are in an otherwise hydrophobic chamber that is accessed through an en- binding resulted in an anomalous difference peak of height 9 r; no density was observed for the hydroxyl product (Supporting Information Fig. 6 ).
Comparison to other HLDs
The DmmA structure is similar to structures of other subfamily II HLDs (0.5-0.7 Å RMSD for 219-226 Ca atoms of proteins that are 38-48% identical overall to DmmA). The largest difference between the most similar structure, DhaA, and DmmA is in lid helix a4 and the core-to-lid linker from b6 to a4 [ Fig. 3(A) ]. As expected, DmmA is less similar to the subfamily I HLDs, DhlA (1.4 Å RMSD for 203 Ca) and DppA (1.9 Å for 209 Ca), which have lower overall sequence identity to DmmA. Structure-function studies of other HLDs have demonstrated that the size of the active site cavity and entry tunnel play a role in substrate specificity 8 and chiral selectivity. 21 DmmA has a larger entry tunnel and wider substrate cleft than other HLDs [ Fig. 3(B) ]. This difference is due primarily to the position of lid helix a4 and the preceding loop, and to a lesser extent to amino acid substitutions within the cavity. The loop and helix a4 are the parts of the DmmA structure that differ most from other HLDs.
Other HLDs with large active sites 17,21 have very broad substrate specificity and react well with larger substrates. 8 DmmA, with an even larger active site, should accommodate substrates of greater size and shape diversity. To test this, we assayed DmmA for dehalogenase activity with several halogenated molecules larger than the 1,3-dibromopropane standard substrate (1,6-dibromohexane, 1,6-dichlorohexane, 1,6-diiodohexane, and bromocyclohexane) ( Table I) . In contrast to those tested previously, 8 DmmA has greater activity for the bromocyclohexane compared to the larger straight-chain substrates. This observation is consistent with the wide cavity of DmmA and suggests that it has robust activity toward other bulky substrates.
Discussion
This work establishes that DmmA is a HLD. The kinetic properties of DmmA with a standard substrate, 1,3-dibromopropane, are within the range reported for other HLDs. However, as for most HLDs, the natural substrates are unknown. Of the two protein variants studied, DmmA short was significantly faster than DmmA long , exhibiting tenfold greater activity. Although most of the additional 43 residues on the N-terminus of DmmA long are disordered, they may interfere with substrate access to the active site, resulting in the reduced activity observed for the longer form of the protein.
The DmmA structure has the same fold and active site position as other HLDs, as expected. Nevertheless, DmmA has unique structural features that set it apart from other enzymes within this class. The active site cavity of DmmA is significantly larger than the cavity of other homologs, which was not predictable from straightforward sequence comparisons to other HLDs of known structure. Instead, sequence differences led to subtle structural variation in the position of helix a4 and the core-to-lid linker, which resulted in a large cavity volume. The size of amino acid side chains lining the active site pocket makes a secondary contribution to the cavity size. The larger cavity volume may confer an ability to accept a wide range of large, bulky substrates compared to other HLDs. Among the larger substrates tested, DmmA had a preference for the bulky bromocyclohexane over corresponding linear molecules. This suggests that the natural DmmA substrate may bear a halogenated ring system. The large active site also suggests the value of DmmA as a potential chemoenzymatic tool for large substrates.
The ultimate biological source of DmmA is unknown, as attempts to amplify dmmA from M. producta (formerly L. majuscula) DNA or to find dmmA in the genome sequence have been unsuccessful. dmmA (originally annotated as curN 23 ) was originally found in the cosmid library developed from an M. producta field isolate, which also contained bacterial symbionts or associants as a microbial consortium. To our knowledge, no other HLD has been found in a cyanobacterium, which also suggests an origin outside M. producta, in a symbiont or associated bacterium. Presumably, the natural function of DmmA is to dehalogenate molecules present in the native marine environment of M. producta. In this respect, M. producta has been a rich source of halogenated metabolites, including in this strain, barbamide, which possesses a trichloromethyl group, 37 and in another strain, jamaicamide, which possesses vinyl chloride and alkynyl bromide groups. 38 Despite its orphan status, the large active-site cavity poises DmmA for development as a new biotechnology tool.
Materials and Methods
Cloning, protein expression, and purification
Gene fragments encoding DmmA were generated from cosmid pLM17, 23 inserted into the pET-24b vector, and verified by sequencing to form pDmmA long (encoding residues 1-341) and pDmmA short (encoding residues 44-341). E. coli strain BL21(DE3) was transformed with the expression plasmid, grown at 37 C in 1 L 2xYT to an OD 600 of 0.5, cooled to 18 C, induced with IPTG (final concentration 0.4 mM) and grown for an additional 18 h. Selenomethionyl (SeMet) DmmA short was produced in the same strain in SeMet minimal media. 39 All purification steps were performed at 4 C.
The cell pellet from 1 L of cell culture was resuspended in 40-mL Buffer A (20 mM Tris pH 7.9, 500 mM NaCl, 10% glycerol) plus 20-mM imidazole, lysed by sonication, and the soluble fraction loaded onto a 5-mL HisTrap Ni NTA column (GE Healthcare 27 .5% PEG3350, and 0.1 M BisTris pH 5.5). Crystals of DmmA long were cyroprotected by a 5-10 s transfer to a mixture of well solution also containing 25% PEG400.
Data collection and structure determination
Data were collected at the GM/CA-CAT beamline 23ID-D at the advanced photon source (APS) at Argonne National Lab (Argonne, IL). A 2.2 Å singlewavelength anomalous diffraction dataset was collected at the wavelength of peak absorption at the selenium edge from a DmmA short SeMet crystal. A 2.9 Å dataset was collected from a DmmA long crystal. All data were processed using the HKL2000 suite. 40 Determination of selenium atomic positions, experimental phasing, density modification phase refinement, and initial model building were performed using the programs SOLVE and RESOLVE. 41, 42 And 22 of the 24 expected selenium positions were identified. The model was finished manually in COOT.
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30 from the CCP4 suite 31 was used for refinement. The DmmA long structure was solved by molecular replacement in Phaser 32 using DmmA short as a search model. Model quality was evaluated with MolProbity. 33 Figures were made using PyMOL 34 and hollow. 35 Electron density was complete throughout the polypeptide chain for both polypeptides for DmmA short (residues 44-341) and DmmA long (residues 38-341). No density was observed for the C-terminal His tag of either DmmA variant or for the first 37 residues of DmmA long .
Enzyme assay
Activity was measured using a pH indicator dyebased colorimetric method. 27 
PDB Coordinates
Coordinate and structure factors for DmmA short have been deposited in the Protein Data Bank with accession number 3U1T.
